[Acute myocarditis due to Coxsackie virus B3 in two infants]. 2009

Marijke van der Meulen, and Gerard J J van Doornum, and Linda J A Corel, and Michiel Dalinghaus, and Pieter L A Fraaij, and Matthijs de Hoog
Erasmus MC-Sophia Kinderziekenhuis, Afd. Kindergeneeskunde, Rotterdam, The Netherlands. m.vandermeulen@erasmusmc.nl

In the spring and summer of 2008 two seriously ill male infants were admitted to a paediatric intensive care unit. Initially, both had a fever, were drinking less and were pale complexioned. Physical examination revealed tachycardia, slow capillary filling and liver enlargement. Within a few hours, both infants developed circulatory and respiratory failure. A chest radiograph showed that the heart was enlarged and echocardiography revealed that the pump function of both ventricles was severely diminished. Myocarditis caused by Coxsackie virus B3 was diagnosed when the virus was demonstrated in serum and faeces. At the last follow-up, one infant still had severe pump function disorders, and the other one died. Coxsackie virus B3 is a non-polio enterovirus that usually causes mild clinical syndromes but is also associated with myocarditis and overwhelming, systemic neonatal infections. In neonates with mild symptoms one should be alert to progression to circulatory insufficiency, especially if the mother experiences a flu-like illness in the perinatal period. Early recognition of heart failure and adequate diagnostic testing for cardiotropic viruses is important as morbidity and mortality is considerable.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D009205 Myocarditis Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. Carditis,Myocarditides
D003384 Coxsackievirus Infections A heterogeneous group of infections produced by coxsackieviruses, including HERPANGINA, aseptic meningitis (MENINGITIS, ASEPTIC), a common-cold-like syndrome, a non-paralytic poliomyelitis-like syndrome, epidemic pleurodynia (PLEURODYNIA, EPIDEMIC) and a serious MYOCARDITIS. Coxsackie Virus Infections,Infections, Coxsackie Virus,Infections, Coxsackievirus,Coxsackie Virus Infection,Coxsackievirus Infection
D004326 Drinking The consumption of liquids. Water Consumption,Water Intake,Drinkings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal
D029822 Enterovirus B, Human A species of ENTEROVIRUS infecting humans and containing 36 serotypes. It is comprised of all the echoviruses and a few coxsackieviruses, including all of those previously named coxsackievirus B. Bornholm Disease Virus,Coxsackievirus A9, Human,Echoviruses,Pleurodynia Virus,Coxsackie A9 Virus,Coxsackie B Viruses,Coxsackieviruses B,Echo Viruses,Human Coxsackievirus A9,Human Enterovirus B,Swine Vesicular Disease Virus,A9 Viruses, Coxsackie,Coxsackie A9 Viruses,Coxsackie B Virus,Disease Virus, Bornholm,Echo Virus,Echovirus,Pleurodynia Viruses,Virus, Bornholm Disease,Virus, Coxsackie A9,Virus, Coxsackie B,Viruses, Coxsackie A9

Related Publications

Marijke van der Meulen, and Gerard J J van Doornum, and Linda J A Corel, and Michiel Dalinghaus, and Pieter L A Fraaij, and Matthijs de Hoog
December 1969, Das Deutsche Gesundheitswesen,
Marijke van der Meulen, and Gerard J J van Doornum, and Linda J A Corel, and Michiel Dalinghaus, and Pieter L A Fraaij, and Matthijs de Hoog
August 1970, The Indian journal of medical research,
Marijke van der Meulen, and Gerard J J van Doornum, and Linda J A Corel, and Michiel Dalinghaus, and Pieter L A Fraaij, and Matthijs de Hoog
May 1987, Clinical cardiology,
Marijke van der Meulen, and Gerard J J van Doornum, and Linda J A Corel, and Michiel Dalinghaus, and Pieter L A Fraaij, and Matthijs de Hoog
August 1961, The Medical journal of Australia,
Marijke van der Meulen, and Gerard J J van Doornum, and Linda J A Corel, and Michiel Dalinghaus, and Pieter L A Fraaij, and Matthijs de Hoog
October 1986, British journal of experimental pathology,
Marijke van der Meulen, and Gerard J J van Doornum, and Linda J A Corel, and Michiel Dalinghaus, and Pieter L A Fraaij, and Matthijs de Hoog
February 2018, Inflammation,
Marijke van der Meulen, and Gerard J J van Doornum, and Linda J A Corel, and Michiel Dalinghaus, and Pieter L A Fraaij, and Matthijs de Hoog
August 1977, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Marijke van der Meulen, and Gerard J J van Doornum, and Linda J A Corel, and Michiel Dalinghaus, and Pieter L A Fraaij, and Matthijs de Hoog
March 2011, Revista peruana de medicina experimental y salud publica,
Marijke van der Meulen, and Gerard J J van Doornum, and Linda J A Corel, and Michiel Dalinghaus, and Pieter L A Fraaij, and Matthijs de Hoog
January 1975, Archivum immunologiae et therapiae experimentalis,
Marijke van der Meulen, and Gerard J J van Doornum, and Linda J A Corel, and Michiel Dalinghaus, and Pieter L A Fraaij, and Matthijs de Hoog
July 1989, American heart journal,
Copied contents to your clipboard!